Photo of Aakash Desai from doximity.com
Sep 16, 2024, 19:38
Aakash Desai: Real-World Data on Immunotherapy Use in Early NSCLC
Aakash Desai Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center shared a post on LinkedIn:
“Real-World Data on Immunotherapy Use in Early NSCLC.
Pleased to share the real-world data on immunotherapy use in early-stage NSCLC presented by our team UAB O’Neal Comprehensive Cancer Center and collaborators at Flatiron Health at ХWCLC24!
Key findings:
- Real-world insights on distant metastasis-free survival in early NSCLC patients
- Analysis of metastasis sites and the need for improved biomarker testing highlighted
Exciting work that underscores the importance of translating clinical research into everyday practice.”
Source: Aakash Desai/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 3, 2024, 11:53
Dec 3, 2024, 11:50
Dec 3, 2024, 11:43
Dec 3, 2024, 09:35